Effects of Nanoliposomal and Pegylated Nanoliposomal Artemisinin in Treatment of Breast Cancer

[1]  Narendra Singh,et al.  Development of artemisinin compounds for cancer treatment , 2013, Investigational New Drugs.

[2]  Ellen Warner,et al.  Clinical practice. Breast-cancer screening. , 2011, The New England journal of medicine.

[3]  Andreas Wagner,et al.  Liposome Technology for Industrial Purposes , 2010, Journal of drug delivery.

[4]  M. Baru,et al.  The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia , 2010, International journal of nanomedicine.

[5]  M. Thanou,et al.  Targeting nanoparticles to cancer. , 2010, Pharmacological research.

[6]  B. K. Park,et al.  Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells. , 2009, Bioorganic & medicinal chemistry.

[7]  Xueying Sun,et al.  Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo , 2009, Anti-cancer drugs.

[8]  Narendra Singh,et al.  Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. , 2008, International journal of pharmaceutics.

[9]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[10]  Hussien O. AlKadi,et al.  Antimalarial Drug Toxicity: A Review , 2007, Chemotherapy.

[11]  C. Cheung,et al.  Experimental study of environmental tobacco smoke particles under actual indoor environment. , 2006, The Science of the total environment.

[12]  Si-Shen Feng,et al.  The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. , 2006, Biomaterials.

[13]  Narendra Singh,et al.  Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. , 2006, Cancer letters.

[14]  A. Mohammed,et al.  Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. , 2004, International journal of pharmaceutics.

[15]  R. Ho,et al.  Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.

[16]  N. White,et al.  Severe allergic reactions to oral artesunate: a report of two cases. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.